Publications by authors named "David Rieman"

Claim this Profile
F
First-in-Human Pharmacokinetics and Safety Study of GSK3008356, a Selective DGAT1 Inhibitor, in Healthy Volunteers.
Malek Okour, Angela Gress, Xinyi Zhu, David Rieman, Jason D Lickliter

Clin Pharmacol Drug Dev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonists.
William H Miller, Peter J Manley, Russell D Cousins, Karl F Erhard, Dirk A Heerding, David J Rieman

Bioorg Med Chem Lett· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.
Sanjay Kumar, Charles R Hanning, Michael R Brigham-Burke, David J Rieman, Ruth Lehr

Cytokine· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis